How Much Collagen Do You Need Per Day?

Collagen Supplements

2.5-15g/day

Clinical trials testing collagen peptide supplements have used doses ranging from 1g to 15g daily, with the effective dose depending on the target outcome.

Proksch et al., Skin Pharmacol Physiol, 2014

Proksch et al., Skin Pharmacol Physiol, 2014

View as image

Collagen peptide supplements are among the most commercially successful peptide products, with global sales exceeding $9 billion annually. The marketing claims are broad: better skin, stronger joints, denser bones, more muscle. The clinical trial evidence is more specific. Randomized controlled trials have tested doses ranging from 1 gram to 15 grams per day across different endpoints, and the effective dose depends entirely on what you are measuring. This article breaks down the dosing evidence by target outcome, drawn directly from the published trial data. For a broader look at whether collagen supplements work at all, see our pillar article on collagen peptides and bone density.

How Collagen Peptides Get Absorbed

Before discussing dose, the absorption question matters. Collagen is a large structural protein. Hydrolyzed collagen (collagen peptides) has been enzymatically broken down into fragments typically between 2,000 and 5,000 daltons, small enough for intestinal absorption via the same PepT1 transporter and paracellular pathways used for dietary protein fragments.

Shigemura and colleagues conducted the most direct dose-response absorption study in 2014. They gave healthy volunteers single oral doses of collagen hydrolysate at 2.5g, 5g, and 10g, then measured plasma levels of free and peptide-bound hydroxyproline (a collagen-specific amino acid) over the following hours.^[5] Plasma hydroxyproline rose in a clear dose-dependent manner: higher oral doses produced proportionally higher blood levels. Peak plasma concentrations occurred 1-2 hours after ingestion. This confirms that oral collagen peptides are absorbed into the bloodstream and that the dose-response relationship is roughly linear across this range.

The absorbed peptides are not just free amino acids. Specific di- and tripeptides like Pro-Hyp (proline-hydroxyproline) and Hyp-Gly (hydroxyproline-glycine) appear in plasma intact, and these fragments have been shown to stimulate fibroblast activity, chondrocyte metabolism, and osteoblast differentiation in cell culture. This is why the dose matters: more collagen ingested means more of these bioactive peptide fragments reach target tissues via the bloodstream. The peptides are detected in blood within 30 minutes of oral ingestion, peak at 1-2 hours, and remain elevated for approximately 4-6 hours before returning to baseline. For more on absorption mechanisms, see our article on hydrolyzed collagen absorption.

Dosing for Skin: 1-5g/day

Skin outcomes have the most trial data at the lowest doses. Several RCTs have demonstrated measurable improvements in skin hydration, elasticity, and wrinkle depth with daily collagen peptide supplementation.

Proksch et al. (2014) conducted a double-blind, placebo-controlled study in 69 women aged 35-55. Participants received either 2.5g or 5g of specific collagen peptides (Verisol) daily for 8 weeks.^[6] Both doses improved skin elasticity compared to placebo. The 2.5g dose was as effective as 5g for elasticity, suggesting a ceiling effect for this specific endpoint. Skin hydration showed a trend toward improvement but did not reach statistical significance at either dose in this particular trial.

Kim et al. (2018) tested low-molecular-weight collagen peptides at 1g/day for 12 weeks in a double-blind RCT. Even at this low dose, participants showed statistically significant improvements in skin hydration (at 6 and 12 weeks), elasticity, and wrinkling compared to placebo.^[1] This is the lowest effective dose demonstrated in a rigorous skin trial.

Myung and Park (2025) published a systematic review and meta-analysis of randomized controlled trials examining collagen supplements for skin aging.^[7] Across the pooled trials, collagen peptide supplementation improved skin hydration, elasticity, and wrinkle parameters. Most included trials used doses between 2.5g and 10g daily over 8-12 weeks.

The skin evidence suggests that 2.5-5g/day is the sweet spot for most skin endpoints, with some evidence that 1g/day may suffice for hydration-specific outcomes. The consistent finding across trials is that collagen peptide supplementation outperforms placebo for at least one skin parameter, regardless of whether the dose is 1g, 2.5g, or 5g. The differences between doses are smaller than the differences between collagen and placebo. For detailed skin trial data, see our article on collagen peptides for skin.

Dosing for Joints: 5-10g/day

Joint pain studies have used higher doses and longer durations than skin trials.

Clark et al. (2008) conducted a 24-week study in 147 athletes with activity-related joint pain. Participants received 10g/day of collagen hydrolysate or placebo.^[2] The collagen group showed statistically significant reductions in joint pain during walking, standing, at rest, carrying objects, and lifting. This is one of the largest and longest collagen joint studies, and it used the highest dose commonly tested.

Kumar et al. (2015) tested collagen peptides in knee osteoarthritis patients using a double-blind RCT design. Oral supplementation significantly reduced pain and improved joint function and quality of life scores over the study period.^[8]

Zdzieblik et al. (2017) found that 5g/day of specific collagen peptides improved activity-related knee joint discomfort in young, physically active adults over 12 weeks.^[9] This suggests that for milder joint symptoms, 5g/day may be sufficient, while more severe or activity-related joint pain may benefit from 10g/day.

Kviatkovsky et al. (2023) tested 10g/day of collagen peptides for 6 months in active adults and found significant improvements in activities of daily living and pain scores.^[10]

For joint outcomes, the evidence points to 5-10g/day as the effective range, with 10g being the dose used in the most robust trials. For a deeper review of the joint evidence, see our article on collagen for joint pain and collagen peptides for joint health.

Dosing for Bones: 5g/day

Bone density trials require longer study periods (12+ months) because bone remodeling is slow.

Konig et al. (2018) conducted a 12-month RCT in 131 postmenopausal women with reduced bone mineral density. Participants received 5g/day of specific collagen peptides (containing bioactive peptides targeting osteoblasts) or placebo.^[3] The collagen group showed statistically significant increases in bone mineral density at the femoral neck and spine, along with favorable changes in bone formation and resorption markers. This is the strongest single bone density trial for collagen peptides.

Only one dose (5g/day) has been rigorously tested for bone density in a powered RCT. Whether lower or higher doses would be more or less effective is unknown. The 5g dose was selected based on the amount needed to deliver sufficient bioactive peptides (particularly Pro-Hyp) shown to stimulate osteoblast activity in preclinical studies.

The 12-month trial duration is important context. Bone remodeling operates on a cycle of approximately 3-6 months, meaning any intervention targeting bone density requires at least one full remodeling cycle to produce measurable changes. The Konig trial's 12-month design captured two or more full remodeling cycles, which is why statistically significant BMD changes were detectable. Shorter collagen supplementation periods would be unlikely to show bone density effects even if the dose were adequate, simply because the biological process is too slow.

Dosing for Muscle: 15g/day

Muscle outcomes require the highest doses in the collagen supplement literature.

Zdzieblik et al. (2015) tested 15g/day of collagen peptides combined with resistance training in elderly sarcopenic men over 12 weeks.^[4] Compared to placebo plus resistance training, the collagen group gained significantly more muscle mass and strength while losing more fat mass. The 15g dose was chosen to provide a protein supplementation level sufficient to impact muscle protein synthesis.

This dose is notably higher than skin or joint doses, reflecting the fact that muscle protein synthesis requires a larger amino acid stimulus. However, collagen is an incomplete protein (it lacks tryptophan and is low in leucine, the amino acid most critical for triggering mTOR-mediated muscle protein synthesis), so it is a less efficient muscle protein source gram-for-gram than whey or casein. The 15g dose compensates for this by providing a larger total amino acid load, primarily glycine, proline, and hydroxyproline.

The mechanism by which collagen peptides support muscle is likely different from whey protein. Rather than directly stimulating muscle protein synthesis through leucine signaling, collagen peptides may support the connective tissue matrix within and around muscle (tendons, fascia, endomysium), which is critical for force transmission and injury resistance. This would explain why 15g of collagen plus resistance training outperformed placebo plus resistance training in sarcopenic men, even though collagen is a poor leucine source. For related evidence on collagen and exercise recovery, see our article on collagen for muscle recovery and collagen for athletes.

The Dose-Response Question

A common question is whether taking more collagen produces proportionally better results. The evidence suggests a nuanced answer:

For skin: the Proksch 2014 trial found no additional benefit from 5g versus 2.5g for skin elasticity, suggesting a plateau effect at relatively low doses. Kim 2018 showed effects at just 1g/day. Above 5g/day, there is no evidence of additional skin benefit.

For joints: trials at 5g and 10g both show benefit, but head-to-head dose comparisons within a single trial have not been published. Whether 10g produces greater joint benefits than 5g is assumed but not directly demonstrated.

For bones and muscle: only single doses have been tested (5g for bone, 15g for muscle), so the dose-response curve for these endpoints is entirely undefined. It is possible that 10g/day would be equally effective for bone density, or that 10g/day would be insufficient for muscle mass in sarcopenic populations. Without multi-dose comparison trials, these questions remain unanswered. The practical consequence is that dosing recommendations for bone and muscle are based on the single dose that happened to be tested, not on any optimization process.

The Shigemura 2014 pharmacokinetic data shows that plasma peptide levels rise proportionally with dose from 2.5g to 10g.^[5] This means higher doses deliver more bioactive peptides to tissues. But whether higher tissue delivery translates to proportionally better clinical outcomes depends on whether the target tissue response is dose-limited or pathway-limited.

What the Evidence Does Not Establish

Most collagen supplement trials are industry-funded, conducted by groups with commercial relationships to collagen manufacturers, and test proprietary collagen peptide formulations (Verisol, Fortigel, PEPTAN). Whether generic collagen hydrolysate at the same dose would produce equivalent results is an open question, because the specific peptide composition and molecular weight distribution vary between products.

Trial durations are relatively short: 8-12 weeks for skin, 12-24 weeks for joints, 12 months for bone. Whether benefits are maintained with continued use, plateau over time, or reverse upon discontinuation is poorly characterized. The Shigemura absorption study was a single-dose pharmacokinetic study, not a long-term efficacy trial.

There are no published trials directly comparing different doses within the same study for skin, joint, or bone outcomes using the same collagen product. The dose recommendations are inferred from separate trials using different products, populations, and outcome measures. A single multi-dose, multi-endpoint trial using a standardized collagen product would clarify the dose-response relationship for the field, but no such trial exists.

Additionally, individual variation in collagen peptide response is not well characterized. Factors like baseline collagen status, digestive enzyme activity, age, sex, and dietary protein intake could all influence how much supplemental collagen is needed to produce a measurable effect. None of these variables have been systematically studied across doses. For a broader look at collagen product comparisons, see our article on marine vs bovine collagen.

The Bottom Line

Clinical trials support different collagen peptide doses for different endpoints: 1-5g/day for skin hydration and elasticity, 5-10g/day for joint pain, 5g/day for bone mineral density, and 15g/day for muscle mass in elderly sarcopenic men. Plasma absorption data confirms dose-dependent delivery of bioactive peptides. Most trials are industry-funded and test proprietary formulations, and direct dose-comparison studies within single trials are lacking. The evidence is strongest for 8-12 week skin outcomes at 2.5-5g/day, and for 12-month bone density at 5g/day.

Frequently Asked Questions

How many grams of collagen should I take per day?

The effective dose depends on the target outcome. Clinical trials show 2.5-5g/day for skin improvements (Proksch et al., 2014), 5-10g/day for joint pain reduction (Clark et al., 2008; Zdzieblik et al., 2017), 5g/day for bone mineral density (Konig et al., 2018), and 15g/day for muscle mass gains in elderly men (Zdzieblik et al., 2015). Skin benefits have been seen at doses as low as 1g/day in one RCT.

Is 5g of collagen enough?

For skin and bone endpoints, 5g/day has shown statistically significant benefits in randomized controlled trials. For joint pain, 5g was effective for mild knee discomfort in active adults (Zdzieblik et al., 2017), though more severe activity-related joint pain has been studied at 10g/day. For muscle mass, 5g would likely be insufficient based on the only positive muscle trial, which used 15g/day.

How long does collagen take to work?

Skin improvements appear earliest: statistically significant changes in hydration at 6 weeks (Kim et al., 2018), elasticity at 8 weeks (Proksch et al., 2014). Joint pain reduction typically requires 12-24 weeks of daily supplementation. Bone mineral density changes require 12 months of supplementation to become measurable (Konig et al., 2018). No trial has shown meaningful results before 6 weeks.

Is there a collagen dose that's too high?

No safety concerns have been reported at doses up to 15g/day in clinical trials lasting up to 12 months. The Proksch 2014 skin trial found no additional benefit from 5g versus 2.5g for skin elasticity, suggesting a plateau effect where higher doses may not produce proportionally greater results for some endpoints. Collagen hydrolysate is generally well-tolerated as a food-derived protein supplement.

Does the type of collagen affect the dose needed?

Possibly. Clinical trials use proprietary collagen peptide formulations (Verisol, Fortigel) with specific molecular weight distributions and peptide compositions. The effective dose may differ between products because the proportion of bioactive di- and tripeptides (like Pro-Hyp) varies by manufacturing process and source. Direct comparisons between collagen products at the same dose have not been published.

Is collagen better absorbed on an empty stomach?

The Shigemura et al. (2014) pharmacokinetic study measured absorption after fasted collagen ingestion, showing peak plasma levels at 1-2 hours. Whether food intake affects absorption rate or total uptake of collagen peptides has not been directly compared in published trials. Most clinical trials do not specify timing relative to meals.